Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-000335
Filing Date
2025-01-21
Accepted
2025-01-21 09:30:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10681
2 JOINT FILING AGREEMENT p25-0138exhibit99_1.htm EX-99.1 4024
  Complete submission text file 0000902664-25-000335.txt   16405
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

EIN.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309
Business Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309 416-861-2267
Flora Growth Corp. (Subject) CIK: 0001790169 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93855 | Film No.: 25540812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)